期刊文献+

线粒体心肌病 被引量:2

Mitochondrial cardiomyopathy
下载PDF
导出
摘要 线粒体是人体所有细胞的能量工厂,是人体有氧代谢的中心,为细胞新陈代谢所必须。线粒体心肌病是指由于线粒体功能障碍而引起的心肌损害,其特点是心肌结构或/和功能异常,典型的临床表现是肥厚型心肌病、扩张型心肌病、心律失常、左室心肌致密化不全和心功能衰竭。文章综述线粒体心肌病的病理生理、临床表现及可能的治疗方法。 Mitochondria are the energy factory of all the cells, the center of aerobic metabolism, and essential for the me-tabolism of cells. Mitochondrial cardiomyopathy refers to myocardial damage caused by mitochondrial dysfunction and is char-acterized by cardiac structural and (or) functional abnormalities. The typical clinical feature of mitochondrial cardiomyopathy is hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmias, noncompaction of left ventricular and heart failure. This article focuses on the pathophysiology, clinical manifestations and possible treatments of mitochondrial cardiomyopathy.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2015年第9期827-830,共4页 Journal of Clinical Pediatrics
关键词 线粒体 心肌病 有氧代谢 线粒体DNA突变 mitochondria cardiomyopathy aerobic metabolism mitochondrial DNA mutations
  • 相关文献

参考文献27

  • 1Janssen AJ, Trijbels F J, Senger RC, et al. Measurement of the energy-generating capacity of human muscle mitochondria:diagnostic procedure and application to human pathology [J]. Clin Chem, 2006, 52(5): 860-871.
  • 2Kisler JE, Whittaker RG. Mitochondrial diseases in childhood: a clinical approach to investigation and management [J]. Dev Med Child Neurol, 2010, 52(5):422-433.
  • 3Meyers DE, Basha HI, Koenig MK, et aL Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management [J]. Tex Heart Inst J, 2013, 40(4):385-394.
  • 4Venditti P, Di Stefano L, Di Meo S. Mitochondrial metabolism of reactive oxygen species [J]. Mitochondrion, 2013, 13(2):71-82.
  • 5Chinnery PF, Elliott HR, Hudson G, et al. Epigenetics, epidemiology and mitochondrial DNA diseases [J]. Int J Epidemiol, 2012, 41(1):177-187.
  • 6Wallace DC. Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine [J]. Annu Rev Biochem, 2007, 76:781-821.
  • 7Limongelli G, Masarone D, D' Alessandro R, et al. Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course [J]. Future Cardiol, 2012, 8(1):71-88.
  • 8Freyer C, Cree LM, Mourier A, et al. Variation in germline mtDNA heteroplasmy is determined prenatally but modified during subsequent transmission [J]. Nat Genet, 2012, 44(11): 1282-1285.
  • 9Sacconi S, Salviati L, Nishigaki Y, et aL A functionally dominant mitochondrial DNA mutation [J]. Hum Mol Genet, 2008, 17(12):1814-1820.
  • 10Hirano M, Davidson M, DiMauro S. Mitochondria and the heart [J]. Curr Opin Cardiol, 2001, 16(3):201-210.

同被引文献3

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部